Back to results
US 10,093,660 B2Granted
Sulfoximine substituted quinazolines for pharmaceutical compositions
AssigneeEvotec Internatonal GmbH
InventorsJoerg Kley, Andreas Blum, Dirk Gottschling, Joerg P. Hehn, Dieter Wiedenmayer
Life of this patent
Estimating the term…
Abstract
This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I), wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
Claims19
A compound of formula
- wherein
- Ar is
- wherein
- X is CH or N;
- R3 is H, halogen, CN or C(═O)—NH2;
- and
- R4 is
- wherein
- is a single or a double bond;
- n is 0 or 1;
- Y is O or NRN1;
- RN1 is selected from the group consisting of H, C1-3-alkyl, —C(O)—C1-3-alkyl, —C(O)—O—(CH2)1-3-phenyl and SO2—C1-3-alkyl;
- R7 is selected from the group consisting of F, CN, OH, —O—(C1-3-alkyl), —O—(CH2)1-3—(C3-7-cycloalkyl), —O—(CH2)1-3-phenyl, —O-oxetanyl and —O—C(O)—C1-4-alkyl;
- and
- R9 is H, or R9 together with R7 form —CH2— or —(CH2)2—;
- wherein each alkyl group mentioned in the definition of RN1 and R7 is optionally substituted with one or more F or —O—(C1-3-alkyl);
- R1 is
- wherein
- R5 is selected from the group consisting of C1-5-alkyl, C2-3-alkenyl, C2-3-alkynyl, C3-7-cycloalkyl, heterocyclyl, heteroaryl, and aryl,
- wherein each alkyl group of R5 is optionally substituted with one or more F or with one —O—(C1-3-alkyl), —O—C3-7-cycloalkyl, —O-heterocyclyl, C3-7-cyclo-alkyl, heterocyclyl or phenyl;
- and
- R6 is C1-3-alkyl which is optionally substituted with one or more F,
- or wherein R5 and R6 together with the sulfur atom to which they are attached form a 3 to 7-membered saturated or partly unsaturated heterocycle that further to the sulfur atom may contain one additional heteroatom selected from the group consisting of O, S and NRN2,
- wherein RN2 is H, C1-3-alkyl, —C(═O)—(C1-3-alkyl), —C(═O)—O—(C1-4-alkyl), —C(═O)—(C1-3-alkyl)-O—(C1-4-alkyl), —C(═O)—NH2, —C(═O)—NH(C1-3-alkyl), —C(═O)—N(C1-3-alkyl)2 or —SO2(C1-4-alkyl);
- and wherein R5, R6 and the heterocycles formed by R5 and R6 together with the sulfur atom to which they are attached may each be independently substituted with halogen, CN, OH, C1-3-alkyl or —O—(C1-3-alkyl);
- and
- R2 is selected from the group consisting of halogen, CN, OH, C1-3-alkyl, C3-5-cycloalkyl and —O—(C1-3-alkyl), wherein each alkyl group is optionally substituted with one or more F;
- and
- Rx is H or halogen;
- and
- wherein, if not otherwise specified, each alkyl group in the above definitions is linear or branched and may be substituted with one to three F;
- or a stereoisomer or salt thereof.
29 more elements
Dependencies are inferred from the claim text.